spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Temperature Maintenance of Biopharmaceuticals in Distribution 2018

14-15 March 2018
Milan, Italy

After an incredibly successful Temperature Maintenance of Biopharmaceuticals in Distribution event, we are excited to announce the event programme for this year’s event!

Our 2017 programme provided a holistic approach to temperature controlled shipments whilst also addressing transportation obstacles and regulatory compliance. Topics included transportation, GDP compliance, qualification systems and case studies from both cold chain and ambient product perspectives.

Whether you are from a small biotech or a large pharma company this event is the perfect platform to share challenges, network with over 400 industry peers and hear informative case studies.

 

2018 Agenda Highlights:

·         Opening Keynote: Discovering Boehringer Ingelheim’s past journey and future ambitions in temperature monitoring

·         Collaborative Panel Discussion: Using Local Distribution Agents Whilst Evaluating the Potential for Shared Risk and Reimbursement

·         Understanding Measures Taken By Airlines to Ensure the Integrity of Products During Transportation to Limit Temperature Excursions

·         Case study: The Hacking Age and the Need for Cyber Security to Avoid Logistical Disasters


2018 Key Speakers:

·        Chris Wallace, Senior Director, International Supply Chain Operations, Genzyme

·        Clemens Twardy, Head of Logistics, Boehringer Ingelheim

·        Francisco Rizzuto, Cargo Specialist, IATA

·        Sven Sachsse, Transport Expert - Supplier Qualification, Bayer

·        Nicola Caristo, Pharma Audit and Compliance Manager, ALHA Group

·        Marc Sotty, Studies and Distribution Head, Sanofi

For more information, please visit: http://www.arena-international.com/pharmatemp?clearcache=1or alternatively email us at: events@arena-international.com

 
Print this page
Send to a friend
   
spacer
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>


News and Press Releases

3P Biopharmaceuticals receives FDA approval

[Pamplona, September 16th, 2019] 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organisation (CDMO) specialized in process development and GMP manufacturing of biologics, receives FDA approval after completing the Pre-Approval Inspection (PAI) conducted at the 3P drug substance manufacturing facility.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement